Basel Committee Returns To Spotlight

michael-shashoua-waters

As summer draws to a close, and we're sorry to see it go, the first big event on the macro horizon for data professionals is the G20 summit in St. Petersburg on September 5–6. One small piece of the big picture at the summit is work on the Basel III regulatory reforms for banks' capital adequacy.

The Basel Committee on Banking Supervision (BCBS) reported to the G20 recently in advance of the summit that regulatory data collection must be improved to better understand risk-weighted assets that are a key element of capital adequacy.

With this latest news, it seems the BCBS is becoming more proactive in filling in gaps and otherwise articulating details of the Basel III rules. This began in June, when the BCBS forbade netting of collateral against derivatives exposures and required exposure calculations to include the amount of collateral in derivatives.

Where I once portrayed the BCBS as lax on Basel III, that continues to change. Watch for more from the Committee during the remainder of this year. There is still suspense in not knowing what other pronouncements it may make, and what their impact could be.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Removal of Chevron spells t-r-o-u-b-l-e for the C-A-T

Citadel Securities and the American Securities Association are suing the SEC to limit the Consolidated Audit Trail, and their case may be aided by the removal of a key piece of the agency’s legislative power earlier this year.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here